Literature DB >> 3988338

Purification and characterization of neurotoxin produced by Clostridium botulinum type C 6813.

J Terajima, B Syuto, J O Ochanda, S Kubo.   

Abstract

The toxin produced by Clostridium botulinum type C 6813 (C-6813) was purified 1,009-fold from the culture supernatant in an overall yield of 30%. The specific toxicity was 1.1 X 10(7) mouse minimum lethal doses per mg of protein. The toxin had a molecular weight of 144,000, composed of the light and heavy chains with molecular weights of 52,000 and 92,000, respectively, linked by one or two disulfide bond(s). The purified C-6813 toxin heavy and light chains reacted strongly with anti-type D heavy chain immunoglobulin G and anti-type C1 light chain immunoglobulin G, respectively. The amino acid compositions of C-6813 toxin heavy and light chains were more similar to those of type D heavy chain and type C1 light chain than to those of type C1 heavy chain and type D light chain, respectively. These results suggest that in the toxin produced by the type C strain at least two subtypes exist.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3988338      PMCID: PMC261306          DOI: 10.1128/iai.48.2.312-317.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  Phage-conversion of toxigenicity in Clostridium botulinum types C and D.

Authors:  K Inoue; H Iida
Journal:  Jpn J Med Sci Biol       Date:  1971-02

3.  Measurement of molecular weights by electrophoresis on SDS-acrylamide gel.

Authors:  K Weber; J R Pringle; M Osborn
Journal:  Methods Enzymol       Date:  1972       Impact factor: 1.600

4.  Statistical analysis of a rapid in vivo method for the titration of the toxin of Clostridium botulinum.

Authors:  D A Boroff; U Fleck
Journal:  J Bacteriol       Date:  1966-11       Impact factor: 3.490

5.  Purification and characterization of two components of botulinum C2 toxin.

Authors:  I Ohishi; M Iwasaki; G Sakaguchi
Journal:  Infect Immun       Date:  1980-12       Impact factor: 3.441

6.  Isolation and molecular size of Clostridium botulinum type C toxin.

Authors:  B Syuto; S Kubo
Journal:  Appl Environ Microbiol       Date:  1977-02       Impact factor: 4.792

7.  Evidence that botulinum C2 toxin has two dissimilar components.

Authors:  M Iwasaki; I Ohishi; G Sakaguchi
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

8.  Quantitation of submicrogram amounts of protein using coomassie brilliant blue R on sodium dodecyl sulfate-polyacrylamide slab-gels.

Authors:  R Kahn; R W Rubin
Journal:  Anal Biochem       Date:  1975-07       Impact factor: 3.365

9.  Vascular permeability activity of botulinum C2 toxin elicited by cooperation of two dissimilar protein components.

Authors:  I Ohishi; M Iwasaki; G Sakaguchi
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

10.  The susceptibility of the mallard duck (Anas platyrhynchos) to Clostridium botulinum C2 toxin.

Authors:  W I Jensen; R M Duncan
Journal:  Jpn J Med Sci Biol       Date:  1980-04
View more
  5 in total

1.  Molecular diversity of neurotoxins from Clostridium botulinum type D strains.

Authors:  K Moriishi; B Syuto; S Kubo; K Oguma
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

2.  Purification and characterization of ADP-ribosyltransferases (exoenzyme C3) of Clostridium botulinum type C and D strains.

Authors:  K Moriishi; B Syuto; N Yokosawa; K Oguma; M Saito
Journal:  J Bacteriol       Date:  1991-10       Impact factor: 3.490

3.  Establishment of a monoclonal antibody recognizing an antigenic site common to Clostridium botulinum type B, C1, D, and E toxins and tetanus toxin.

Authors:  K Tsuzuki; N Yokosawa; B Syuto; I Ohishi; N Fujii; K Kimura; K Oguma
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

4.  Molecular cloning of the gene encoding the mosaic neurotoxin, composed of parts of botulinum neurotoxin types C1 and D, and PCR detection of this gene from Clostridium botulinum type C organisms.

Authors:  K Moriishi; M Koura; N Fujii; Y Fujinaga; K Inoue; B Syuto; K Oguma
Journal:  Appl Environ Microbiol       Date:  1996-02       Impact factor: 4.792

5.  Effect of nicking the C-terminal region of the Clostridium botulinum serotype D neurotoxin heavy chain on its toxicity and molecular properties.

Authors:  Tomonori Suzuki; Hirokazu Kouguchi; Toshihiro Watanabe; Kimiko Hasegawa; Tohru Yoneyama; Koichi Niwa; Atsushi Nishikawa; Jae-Chul Lee; Keiji Oguma; Tohru Ohyama
Journal:  Protein J       Date:  2007-04       Impact factor: 4.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.